Mesoblast (MESO) Other Non-Current Liabilities (2015 - 2025)

Mesoblast's (MESO) quarterly Other Non-Current Liabilities came in at $14.2 million in Q4 2025, down 48.59% year-on-year from $27.6 million in Q4 2024, and up 147.59% quarter-over-quarter from $5.7 million in Q2 2025.

Mesoblast (MESO) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends

Mesoblast has disclosed Other Non-Current Liabilities across 11 years of filings, most recently posting $14.2 million for Q4 2025.

  • Other Non-Current Liabilities for Q4 2025 came in at $14.2 million, down 48.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.2 million (down 48.59% YoY), and the FY2025 annual result was $5.7 million, down 46.1% from the prior year.
  • Other Non-Current Liabilities came in at $14.2 million for Q4 2025 at Mesoblast, up from $5.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $27.6 million in Q4 2024 to a low of $2.2 million in Q2 2022.
  • The 5-year median for Other Non-Current Liabilities is $17.7 million (2022), against an average of $15.6 million.
  • Across the five-year window, Other Non-Current Liabilities surged 148.33% in 2023 and slumped 48.59% in 2025, its largest moves.
  • Mesoblast's Other Non-Current Liabilities stood at $22.3 million in 2021, then slipped by 19.9% to $17.9 million in 2022, then decreased by 4.37% to $17.1 million in 2023, then soared by 61.47% to $27.6 million in 2024, then plunged by 48.59% to $14.2 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $14.2 million (Q4 2025), $5.7 million (Q2 2025), and $27.6 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mesoblast 21.68 Bn 21.55 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 14.17 Mn
Jun 30, 2025 5.72 Mn
Dec 31, 2024 27.57 Mn
Jun 30, 2024 10.62 Mn
Dec 31, 2023 17.07 Mn
Jun 30, 2023 5.43 Mn
Mar 31, 2023 17.58 Mn
Dec 31, 2022 17.85 Mn
Sep 30, 2022 19.46 Mn
Jun 30, 2022 2.19 Mn
Mar 31, 2022 20.22 Mn
Dec 31, 2021 22.29 Mn
Sep 30, 2021 19.65 Mn
Mar 31, 2021 18.76 Mn
Dec 31, 2020 19.44 Mn
Sep 30, 2020 22.22 Mn
Jun 30, 2020 29.20 Mn
Mar 31, 2020 28.11 Mn
Dec 31, 2019 30.38 Mn
Sep 30, 2019 30.56 Mn